Newbridge Financial Services Group’s Pacific Biosciences PACB Stock Holding History

Newbridge Financial Services Group’s Portfolio PACB Stock Details PACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-6,000	Closed	-$7.68K	–	1371
2025 Q3	$7.68K	Hold	6,000	–	–	﹤0.01%	948
2025 Q2	$7.44K	Hold	6,000	–	–	﹤0.01%	952
2025 Q1	$7.08K	Hold	6,000	–	–	﹤0.01%	744
2024 Q4	$11K	Hold	6,000	–	–	﹤0.01%	715
2024 Q3	$10.2K	Hold	6,000	–	–	﹤0.01%	427
2024 Q2	$8.22K	Buy	+6,000	New	+$12.1K	﹤0.01%	746
2022 Q2	–	Sell	-957	Closed	-$9K	–	1475
2022 Q1	$9K	Buy	957 +558	+140%	+$6.42K	﹤0.01%	968
2021 Q4	$8K	Buy	+399	New	+$9.63K	﹤0.01%	973

Other funds holding PACB

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Newbridge Financial Services Group's PACB Position: Q4 2025 in Review

Newbridge Financial Services Group sold out of Pacific Biosciences (PACB) in Q4 2025, closing a stake of 6,000 shares — an estimated $7.68K sold.

Newbridge Financial Services Group first reported a position in PACB in Q4 2021 and held it in 8 quarters. The position peaked at $11K in Q4 2024. 215 funds tracked by Wall St. Rank hold PACB as of Q4 2025.

Newbridge Financial Services Group reported no remaining Pacific Biosciences position as of Q4 2025 after selling out during the quarter.
Newbridge Financial Services Group sold 6,000 Pacific Biosciences shares in Q4 2025, an estimated $7.68K.
Newbridge Financial Services Group first reported a position in Pacific Biosciences in Q4 2021 and held it in 8 quarters.
Newbridge Financial Services Group's Pacific Biosciences position peaked at $11K in Q4 2024.
215 funds tracked by Wall St. Rank held Pacific Biosciences as of Q4 2025.

Based on Newbridge Financial Services Group's 13F filing for Q4 2025, filed 21 Jan 2026.